Amir Moradi, MD, MBA

Private Practice
2023 West Vista Way
Suite F
Vista, CA
USA 92083
Papers:
Treatment of Moderate-to-Severe Glabellar Lines with Relabotulinumtoxina, a New Liquid Botulinum Toxin: Clinical Efficacy and Safety Results from the Ready-1 Phase III Trial